Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Psychopharmacology

• Publication date

  2018-03-21

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881118762073PMID 29561204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression

  2017cited by this paper
• Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders

  2017cited by this paper
• Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders

  2016cited by this paper
• Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

  2015cited by this paper
• Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.

  2014cited by this paper
• Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder.

  2014cited by this paper
• Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

  2014cited by this paper
• Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

  2013cited by this paper
• Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

  2013cited by this paper
• A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.

  2013cited by this paper
• Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer

  2012cited by this paper
• Use of oral ketamine in chronic pain management: A review

  2010cited by this paper
• Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

  2010cited by this paper
• Ketamine produces effective and long‐term pain relief in patients with Complex Regional Pain Syndrome Type 1

  2009cited by this paper
• Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.

  2006cited by this paper
• The Work and Social Adjustment Scale: a simple measure of impairment in functioning.

  2002influential reference
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Measurement of Dissociative States with the Clinician-Administered Dissociative States Scale (CADSS)

  1998cited by this paper
• Is there a pathophysiological and therapeutic link between panic disorder and epilepsy?

  1995cited by this paper
• Generalized anxiety disorder in women. A population-based twin study.

  1992cited by this paper
• The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia.

  1992cited by this paper
• Evidence for a General Neurotic Syndrome

  1990cited by this paper
• The Aetiology of Post-traumatic Morbidity: Predisposing, Precipitating and Perpetuating Factors

  1989cited by this paper
• Brief standard self-rating for phobic patients.

  1979cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.

  2026cites this paper
• Bifunctional modulation of NMDA and opioid receptors in ketamine reinforcement and misuse: implications for substance use disorder treatment.

  2025cites this paper
• Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review

  2025influential citation
• Ketamine and Esketamine in Psychiatry: A Comparative Review Emphasizing Neuroplasticity and Clinical Applications

  2025cites this paper
• INTEGRATIVE SYSTEMATIC REVIEW ON PHARMACOLOGICAL, PSYCHOTHERAPEUTIC AND NEUROSTIMULATORY TREATMENT OPTIONS IN TREATMENT-RESISTANT ANXIETY DISORDERS.

  2025cites this paper
• New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

  2025cites this paper
• Eficácia da cetamina e esketamina no tratamento da depressão: revisão das evidências e perspectivas futuras

  2025cites this paper
• Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

  2025cites this paper
• Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review

  2025influential citation
• Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review.

  2025cites this paper
• Antidepressant Efficacy of Ketamine Plus Naltrexone for Major Depression Comorbid with Alcohol Use Disorder: A Randomized Controlled Trial.

  2025cites this paper
• Cannabis Use and Its Interaction with Anxiety Disorders

  2024cites this paper
• Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?

  2024cites this paper
• Improvement of Mental Health Symptoms in Response to Ketamine Therapy in Medicaid-Eligible Patients

  2024cites this paper
• Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder

  2023cites this paper
• Efficacy and Safety of Psychedelics in Treating Anxiety Disorders

  2023cites this paper
• A systematic review of the incidence of medical serious adverse events in sub-anesthetic ketamine treatment of psychiatric disorders.

  2023cites this paper
• Ketamine in neuropsychiatric disorders: an update

  2023cites this paper
• Long term structural and functional neural changes following a single infusion of Ketamine in PTSD

  2023cites this paper
• Clínicas de ketamina: usos actuales según la evidencia

  2023cites this paper
• Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions

  2023cites this paper
• Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

  2023cites this paper
• Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study

  2022cites this paper
• Melatonin as a Potential Approach to Anxiety Treatment

  2022influential citation
• A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects

  2022influential citation
• The Effect of the Low Glutamate Diet on the Reduction of Psychiatric Symptoms in Veterans With Gulf War Illness: A Pilot Randomized-Controlled Trial

  2022cites this paper
• Asleep DBS under ketamine sedation: Proof of concept.

  2022cites this paper
• Proposal for a new diagnosis: Acute anxiety disorder

  2022cites this paper
• Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability

  2022cites this paper
• At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.

  2022cites this paper
• Therapeutic Potential of Ketamine for Alcohol Use Disorder.

  2021cites this paper
• Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity

  2021cites this paper
• Panic Disorder: A Review of Treatment Options

  2021cites this paper
• Modulating amygdala activation to traumatic memories with a single ketamine infusion

  2021cites this paper
• Depression as a Failed Anxiety: The Continuum of Precision-Weighting Dysregulation in Affective Disorders

  2021cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2021cites this paper
• Ketamine in Psychiatric Disorders

  2021cites this paper
• Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker

  2021cites this paper
• Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress

  2021cites this paper
• Ketamine treatment for refractory anxiety: A systematic review

  2021cites this paper
• Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study

  2021cites this paper
• Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

  2021cites this paper
• Ketamine Sedation Facilitates Asleep DBS: a multicenter retrospective study

  2021cites this paper
• Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

  2021cites this paper
• Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

  2021cites this paper
• Current trends in treatment of generalised anxiety disorder

  2020cites this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2020cites this paper
• Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology

  2020cites this paper
• Aktuální trendy v léčbě generalizované úzkostné poruchy

  2020cites this paper
• The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

  2020cites this paper
• Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale

  2020influential citation
• Ketamine Pre-Exposure Does Not Influence Later-Life Responses To Reward-Related Stimuli In Female C57bl/6 Mice

  2020cites this paper
• The Effect of Propofol on a Forced Swim Test in Mice at 24 Hours

  2020cites this paper
• Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice

  2020cites this paper
• Ketamine blocks the correlation between morphine-induced conditioned place preference and anxiety-like behaviors in mice

  2020cites this paper
• Repurposing Potential of Ketamine: Opportunities and Challenges

  2020influential citation
• A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

  2020cites this paper
• Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study

  2020cites this paper
• Primate ventromedial prefrontal cortex and the physiological and behavioural dysfunction characteristic of mood and anxiety disorders

  2019cites this paper
• Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review

  2019cites this paper
• The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice.

  2019cites this paper
• Ketamine effects on anxiety and fear-related behaviors: current literature evidence and new findings

  2019cites this paper
• Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

  2019cites this paper
• Rapid and sustained improvement in treatment-refractory depression through use of acute intravenous ketamine and concurrent transdermal selegiline: A case series.

  2019cites this paper
• Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.

  2019cites this paper
• Therapeutic strategies for social anxiety disorder: where are we now?

  2019cites this paper
• Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders.

  2019cites this paper
• Ketamine for Psychiatric Disorders

  2019cites this paper
• Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature

  2019influential citation
• An update on ketamine and its two enantiomers as rapid-acting antidepressants

  2018cites this paper
• Ketamine as a Rapid Antidepressant

  2018cites this paper